Skip to main content
Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
1.940
-0.100 (-4.90%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Mersana Therapeutics Revenue

Mersana Therapeutics had revenue of $2.29M in the quarter ending June 30, 2024, a decrease of -78.48%. This brings the company's revenue in the last twelve months to $29.94M, down -22.68% year-over-year. In the year 2023, Mersana Therapeutics had annual revenue of $36.86M with 38.65% growth.

Revenue (ttm)
$29.94M
Revenue Growth
-22.68%
P/S Ratio
7.86
Revenue / Employee
$243,390
Employees
123
Market Cap
237.99M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202336.86M10.27M38.65%
Dec 31, 202226.58M26.54M61,716.28%
Dec 31, 202143.00K-785.00K-94.81%
Dec 31, 2020828.00K-41.30M-98.03%
Dec 31, 201942.12M31.53M297.61%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Rigel Pharmaceuticals 130.20M
Nektar Therapeutics 93.16M
Enanta Pharmaceuticals 71.96M
2seventy bio 44.12M
aTyr Pharma 588.00K
Revenue Rankings

MRSN News

More News